Results 141 to 150 of about 11,372 (280)

Antimicrobial susceptibility and clinical outcomes of Candida parapsilosis bloodstream infections in a tertiary teaching hospital in Northern Taiwan [PDF]

open access: yes, 2015
BackgroundCandida parapsilosis is an emerging non-albicans Candida that is associated with central line-associated infection. C. parapsilosis has higher minimal inhibitory concentration to echinocandin than Candida albicans, and the effects of ...
Hsieh, Feng-Chih   +4 more
core   +1 more source

Initial results from a longitudinal international surveillance programme for anidulafungin (2003) [PDF]

open access: bronze, 2004
S. A. Messer   +4 more
openalex   +1 more source

Efficacy of anidulafungin in 539 patients with invasive candidiasis: a patient-level pooled analysis of six clinical trials

open access: yesJournal of Antimicrobial Chemotherapy, 2017
Objectives: To evaluate the efficacy of anidulafungin for the treatment of candidaemia and invasive candidiasis in a large dataset, including patients with deep-seated tissue candidiasis, neutropenia and infection due to non-albicans Candida species ...
B. Kullberg   +12 more
semanticscholar   +1 more source

The Surgical Infection Society revised guidelines on the management of intra-abdominal infection [PDF]

open access: yes, 2017
Background: Previous evidence-based guidelines on the management of intra-abdominal infection (IAI) were published by the Surgical Infection Society (SIS) in 1992, 2002, and 2010. At the time the most recent guideline was released, the plan was to update
Chang, Phillip K   +11 more
core   +3 more sources

Expansion of a recent class of broad-spectrum antifungal agents: the echinocandins

open access: yesMicrobiologia Medica, 2009
The echinocandins show comparable efficacy in the treatment of candidemia and invasive candidiasis. Caspofungin and micafungin appear to be similarly efficacious in salvage therapy in aspergillosis; anidulafungin has excellent in vitro activity against ...
Roberto Manfredi
doaj   +1 more source

Safety and tolerability of combination anidulafungin (ANID) and liposomal amphotericn B (LAmB) for the treatment of invasive aspergillosis (IA) [PDF]

open access: hybrid, 2004
Raoul Herbrecht   +9 more
openalex   +1 more source

In Vitro Synergy Testing of Anidulafungin with Itraconazole, Voriconazole, and Amphotericin B against Aspergillus spp. and Fusarium spp [PDF]

open access: green, 2005
Annie Philip   +6 more
openalex   +1 more source

In Vivo Pharmacodynamic Characterization of Anidulafungin in a Neutropenic Murine Candidiasis Model [PDF]

open access: green, 2007
David R. Andes   +6 more
openalex   +1 more source

Intravenous Solution Wastage in Hospital Pharmacy at Baptist Memorial Hospital-North Mississippi (Oxford) [PDF]

open access: yes, 2017
Introduction: IV solution wastage refers to IV medications made for a patient that remain unused by that patient for a variety of reasons, and have subsequently expired, or for other reasons cannot be used for another patient (recycled), and therefore ...
Zhang, Yujing
core   +1 more source

Pharmacokinetics of echinocandins in suspected candida peritonitis: A potential risk for resistance

open access: yesInternational Journal of Infectious Diseases, 2020
Introduction: A possible increase in Candida resistance, especially in Candida glabrata, has been speculated according to poor diffusion of echinocandins to peritoneal fluid.
Francesca Gioia   +7 more
doaj  

Home - About - Disclaimer - Privacy